Julia Mano Johnson is a partner in the firm's litigation department. Ms. Johnson’s practice centers primarily on pharmaceutical patent litigation under the Hatch-Waxman Act. She has been involved in all aspects of the pretrial, trial, and post-trial phases of patent infringement cases, including taking numerous depositions, conducting cross-examinations of fact and expert witnesses, and drafting post-trial briefs. Her representations span a variety of drug products including Aloxi®, Amrix®, Angiomax®, Gralise®, Nasacort AQ®, Seroquel XR®, and Temodar®. Most recently, Ms. Johnson participated in a bench trial for Barr and Teva in the District of Delaware involving patents for the muscle relaxant Amrix®. After a bench trial on the merits, the district court found the Amrix® patents invalid for obviousness. Ms. Johnson’s additional recent trial and post-trial briefing experience include a case involving two patents listed in connection with the nasal spray Nasacort AQ®, a case involving a patent listed in connection with the chemotherapy drug Temodar®, and a case involving a patent listed in connection with the antidepressant Seroquel XR®.
In addition to pharmaceutical patent litigation, Ms. Johnson has experience in a variety of areas including product liability, white-collar criminal defense, corporate internal investigations, SEC enforcement actions, and complex commercial litigation. Ms. Johnson also was a member of the trial team that represented former Illinois Gov. George Ryan in a six-month public corruption trial.
Ms. Johnson is a member of the PAWS Chicago Professional Board. She also serves as a judge in Northwestern University School of Law’s Julius H. Miner moot court competition. Ms. Johnson holds an Advanced-level certification from the U.K. based Wine & Spirit Education Trust and a French Wine Scholar certification from the French Wine Society.
Ms. Johnson received a B.S. in Microbiology, with honors, from the University of Wisconsin in 2000 and a J.D., cum laude, from Northwestern University School of Law in 2004, where she was an executive note and comment development editor of the Northwestern University Law Review.